DF-3001

N/A

Report date: 2022/09/06 18:04:00

Base Information

Drug NameDF-3001
Drug Alias NameDF-3001
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionNatural killer cells stimulantsImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDragonfly Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesDragonfly Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A